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Biomonitoring of exposure to pesticides
involves the measurement of a pesticide(s), its
metabolite(s), or reaction product(s) in biolog-
ical media such as urine, blood, or blood com-
ponents and tissues (Anwar 1997; Barr et al.
1999; He 1993, 1999). Although biomonitor-
ing has been used in many occupational and
environmental health and exposure studies
(Acquavella et al. 2004; Arbuckle et al. 1999;
Azaroff 1999; Coronado et al. 2004; Curl
et al. 2002; Rees 1996; Shealy et al. 1996;
Thompson et al. 2003), we are only beginning
to understand the complexities and uncertain-
ties involved with the biomonitoring process—
including chemical toxicokinetics, matrix
considerations, the appropriateness of the use
of biomonitoring, study design, sample collec-
tion, and chemical analysis—and with inter-
preting the resulting data. We present an
overview of concepts that should be considered
when using biomonitoring or biomonitoring
data, assess the current status of biomonitor-
ing, and detail potential advances in the ﬁeld
that may improve our ability to both collect
and interpret biomonitoring data.
To begin, we deﬁne a few critical terms and
phrases used in this article. “Internal dose” is
defined as the amount of a chemical that is
absorbed into the body after an exposure has
occurred. Although we use the term “exposure”
while discussing biomonitoring, biological
measurements are not actually measuring expo-
sure as classically deﬁned; they are used to assess
exposure by estimating the internal dose. A
“biomarker” is a chemical or metabolite meas-
ured in biological matrices to assess exposure to
a given chemical. “Biomarker measurements”
and “biological measurements” may be used
interchangeably in the text and are generally
expressed on a whole-volume (e.g., micrograms
per liter) or a creatinine-adjusted (micrograms
per gram creatinine) basis. Given many
assumptions about uptake, metabolism, steady-
state excretion, and other factors, biomonitor-
ing measurements or concentrations can be
used to provide a rough estimate of an internal
dose, typically expressed as micrograms per
kilogram per day. “Excretion” is deﬁned as the
amount of a pesticide or metabolite eliminated
from the body during a given time period;
excretion should not be confused with the con-
centration of a chemical in a single sample. A
“biomolecular adduct” is deﬁned as a covalent
chemical link between the pesticide and pro-
teins (e.g., hemoglobin, albumin, or butyryl or
acetyl cholinesterase) or DNA. The terms
“toxicokinetics” and “pharmacokinetics” are
often used interchangeably to deﬁne the biolog-
ical processing of a putative toxicant in the
body; however, in this article, we use the term
“toxicokinetics” to describe the behavior of a
nonpersistent pesticide (NPP) in the body.
General Toxicokinetics
After exposure to an NPP, a portion of the
pesticide may be absorbed into the blood-
stream, distributed among the bodily tissues,
metabolized, and/or excreted. These four
complex steps of absorption, distribution,
metabolism, and excretion (ADME) make up
the toxicokinetic process after a pesticide con-
tacts and enters the body (Klaassen 2001). To
assess human exposure to a given pesticide,
measurements of the pesticide can be made
after the absorption step or during each subse-
quent step of ADME. Biomonitoring is a
measurement of the concentration or dose of
the chemical during or after ADME, and its
concentration level depends on the amount of
the chemical that has been absorbed into the
body, the toxicokinetics (ADME) of the
chemical in that body, and the exposure sce-
nario (including the time sequence of expo-
sure and time since last exposure) (Barr et al.
2005a). Biomonitoring data are typically inde-
pendent of the pathway of exposure. They
integrate exposures from different routes and
reﬂect the amount of the chemical that is in
the matrix sampled, which is some portion of
what actually entered the body. However,
how and where a pesticide is metabolized can
affect the chemical measured and the timing
the sampling should occur. With knowledge
of the toxicokinetics, the internal dose can
then be estimated by measuring the level of a
chemical, its metabolite, or its reaction
product (a chemical adduct) in a biological
medium. The biomarker concentration is
dependent upon the matrix and when in the
ADME process the biological sample is taken,
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after the distribution step. Ideally, to link the
dose with any health outcomes, we would pre-
fer to measure the biologically effective dose,
the dose at the target site that induces an
effect. Often, however, the target organ is not
known, and even if known, it is usually not
available for sampling. In these situations, we
measure the level of the chemical in another
biological sample, such as urine or blood, to
gauge the internal dose.
Matrices for Biomonitoring
Measurements
Nonpersistent organic chemicals such as cur-
rent-use pesticides can be challenging to
measure from both a sample collection and a
chemical analysis point of view (Barr et al.
1999, 2003, 2005a; Koch et al. 2002). The
route of exposure for farmworkers, depending
on the scenario, is primarily dermal; however,
other routes may dominate for nonoccupa-
tional exposures. NPP may be absorbed and
distributed throughout the body based on
their chemical and physical properties. They
are generally metabolized rapidly, and their
metabolites are eliminated in urine (Figure 1).
Urinary metabolites can usually be measured
up to several days after an exposure has
occurred. These measurements represent only
a snapshot in time; thus, only exposures that
occurred during the previous few days would
be captured, depending upon the magnitude
of the exposure. When chronic exposure
occurs, the exposure is continually replenish-
ing the chemical in the blood. Urinary elimi-
nation may reach a steady state (Figure 2);
that is, the chemical or metabolite present in
the urine stays at a relatively constant level. In
these instances, a single urinary measurement
may reﬂect the average exposure over a longer
period. The deposition matrices, such as adi-
pose tissue, are minor matrices for monitoring
NPPs because only small amounts, if any, of
the pesticides are retained in body tissues.
The two primary matrices used to assess
human exposure to pesticides are urine and
blood (e.g., serum, plasma, blood cells)
(Angerer and Gundel 1996; Needham and
Sexton 2000). The volume of blood in a per-
son’s body is relatively constant and consis-
tent from person to person; adults typically
have about 5 L of blood (Klaassen 2001).
Urine volume, of course, is not constant. One
of the major advantages of using urine in
biomonitoring is the ease of its collection for
spot or grab (untimed) urine samples; how-
ever, collection of 24-hr urine voids can be
very cumbersome and may result in non-
adherence. Therefore, spot urine samples,
whether ﬁrst-morning voids or “convenience”
samplings, are most generally used for bio-
monitoring purposes. The major disadvan-
tages of spot urine samples include the
variability of the volume of urine and the
concentrations of endogenous and exogenous
chemicals from void to void (Barr et al.
1999). How best to adjust the urinary con-
centrations of pesticides is the subject of con-
tinued research and much debate.
Blood has also been used as a matrix for
biomonitoring (Driskell et al. 1991; Saito
et al. 1984; Sancho et al. 2000). Blood meas-
urements are usually more speciﬁc for a pesti-
cide because the parent chemical is generally
measured, as opposed to its metabolite; how-
ever, urinary measurements are equally speciﬁc
if the parent compound is excreted in urine
[e.g., 2,4-dichlorophenoxyacetic acid (2,4-D),
glyphosate, sulfonyl ureas]. For example, if
someone is exposed to chlorpyrifos, we can
measure chlorpyrifos in the blood rather than
its metabolite, 3,5,6-trichloro-2-pyridinol
(TCPY), which is formed from more than one
parent chemical (i.e., chlorpyrifos and chlor-
pyrifos methyl) and is also the same chemical
as environmentally degraded chlorpyrifos. The
blood measurement of chlorpyrifos would
offer more chemical speciﬁcity than measure-
ment of urinary TCPY. Because we know how
much blood is in the body, we can calculate
the body burden (i.e., the amount of chemical
relative to the amount of blood in the body)
more accurately than if we measure the chemi-
cal or its metabolite in urine. However, NPPs
tend to have very short half-lives in blood, and
the concentrations are usually about 3 orders
of magnitude lower than urinary metabolite
levels (Barr et al. 2002). Thus, if blood is used
as a matrix, the sensitivity of the analytical
method and the matrix volume available for
analysis may become important. Blood can
also be a valuable matrix for measuring bio-
molecular adducts such as DNA, hemoglobin,
or albumin adducts (Anwar 1997). Typically
when blood is used for this type of measure-
ment, special sample collection and/or prepa-
ration procedures, such as washing red blood
cells (hemoglobin adducts) or isolation of
white cells (DNA adducts), may be required.
However, if analytical requirements such as
cost and speed of analysis are not critical
issues, adduct measurements may provide
more relevant information for relating to
selected health end points such as cancer.
Furthermore, adducts provide a longer win-
dow for capturing an exposure because the
lifetime of an adduct in the body is largely
dependent upon the lifetime of the biomole-
cule itself. For example, hemoglobin has a life-
time of about 120 days; thus, a hemoglobin
adduct could be measured weeks or months
after an exposure has occurred.
If blood testing is used, the stability of
both the matrix and the target pesticide in the
blood should be considered. If testing is not
performed soon after sample collection,
which is often the case, long-term storage of
blood may be problematic, depending upon
what form of blood is stored. Serum stores
well at –70°C because it is low in protein and
stays homogeneous. Plasma contains more
proteins, which precipitate making plasma
less homogeneous than serum. Whole blood
does not store well because the cells tend to
hemolyze. Also, many pesticides are reactive
in blood; thus, the stability of the pesticide in
this matrix under the desired storage condi-
tions should be evaluated.
Saliva has also been explored as a matrix
for measuring selected nonpersistent chemi-
cals, such as atrazine and diazinon (Borzelleca
and Skalsky 1980; Denovan et al. 2000; Lu
et al. 1997a, 1997b, 1998, 2003). Several ani-
mal studies (Lu et al. 1997a, 1997b, 1998,
2003) have shown that pesticides can be meas-
ured in rat saliva. In these studies, atrazine, a
member of triazine herbicide family, and
diazinon, an organophosphorus pesticide,
were measured in both saliva and plasma after
controlled dose administration. The concen-
trations of these two pesticides in saliva and
plasma were signiﬁcantly correlated, and this
correspondence was not affected by factors
such as salivary flow rates. Denovan et al.
(2000) developed a saliva sampling protocol in
which multiple daily saliva samples were col-
lected from a cohort of herbicide applicators
who sprayed atrazine and other triazine herbi-
cides in the Ohio Valley. The results indicated
that saliva can be used to assess atrazine expo-
sure and its elimination in humans. Several
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Figure 1. Hypothetical postexposure fate of an NPP
after a single exposure, represented by the y-axis.
Adapted from Needham and Sexton (2000).
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Figure 2. Hypothetical postexposure fate of an NPP in
blood and urine after repeated (chronic) exposures.field studies are being conducted to evaluate
saliva biomonitoring in humans. The existing
data indicate that saliva levels can be consider-
ably lower than blood levels of a pesticide,
depending upon the degree of protein binding
that may occur; thus, a very sensitive analytical
technique is required. Further research on
additional chemicals and the relation of these
measurements to more commonly used
approaches is required before this can be rou-
tinely used for analysis. However, measure-
ment of pesticides in saliva has great potential
because of the convenience of sampling and
analysis and the potential accuracy of salivary
concentrations as an indicator of tissue avail-
ability (Arcury et al. 2003; Quandt et al.
2001). These advantages would allow
researchers to routinely collect multiple saliva
samples in 1 day for a period of time from a
larger group of individuals, allowing better
characterization of within- and between-
worker variability, thereby reducing uncertain-
ties in estimating daily exposure and absorbed
dose. However, issues surrounding inter- and
intraindividual variability in saliva ﬂow rates,
external contamination of samples, and small
sample volumes must be addressed before
saliva becomes a more viable matrix for farm-
worker biomonitoring.
Dermal Dosimetry versus
Biomonitoring
Two exposure measurement approaches—
dosimetry and biomonitoring—have generally
been used in farmworker exposure assessments.
Each approach has advantages and disadvan-
tages based on information provided, uncer-
tainty, participant burden, and resource
requirements. The first approach, which is
described in more detail in the environmental
workgroup report (Hoppin et al. 2006), typi-
cally uses a set of dermal dosimeter measure-
ments for an individual collected during a
speciﬁc set of work activities. Collection of der-
mal dosimeter and other environmental sam-
ples have the advantage of providing
information about speciﬁc routes of exposure
and also provide exposure information that is
directly related to the particular activity being
monitored (Hoppin et al. 2006). However,
these types of samples can measure only the
potential exposure. A number of assumptions
and empirical parameters about the transport
of the target chemical onto and through the
skin and lungs are required in order to estimate
an internal dose. Unfortunately, those assump-
tions and empirical parameters usually dictate
the magnitude of the estimated internal dose.
Biological measurements certainly can
provide better evidence of the occurrence of
exposure and the subsequent absorption that
brings us closer to the more toxicologically
relevant measure of internal dose. Nevertheless,
biomonitoring is subject to toxicokinetic and
exposure scenario uncertainties that may limit
their use for dose estimation, assessment of
exposure factors, and identiﬁcation of routes
of exposure. The biomarker accounts for all
exposures and routes of exposure and can
potentially provide information for dose esti-
mation. A single measurement of urinary con-
centration can provide an indication of the
presence or absence of exposure, but the quan-
titative calculation of absorbed dose is weak-
ened by intraindividual genetic variability and
the unknown excretion kinetics for individual
pesticides under different routes of exposures
(oral vs. dermal vs. inhalation).
Collection of blood or multiday urine
sample collections can be burdensome; how-
ever, these measurements typically help pro-
vide a more meaningful picture of the
exposure. Other pesticide exposures not
related to the farmwork activities being stud-
ied may make interpretation of exposure pre-
diction factors difficult. Interindividual
differences in toxicokinetics present chal-
lenges in comparing results of metabolite
measurements among different people.
When Is Biomonitoring
Appropriate?
Biomonitoring has been successfully used in
many farmworker exposure studies. Studies are
often focused on task-based assessments, for
example, exposures resulting from uses of dif-
ferent chemical handling and application meth-
ods (Coronado et al. 2004; Grover et al. 1986a,
1986b), harvesting or thinning operations
(Coronado et al. 2004; McCurdy et al. 1994),
or uses of personal protective equipment
(Ojanen et al. 1992). Other studies have exam-
ined multiple exposure factors (Acquavella et al.
2004; Arbuckle et al. 2002; Arcury et al. 2005;
Hines and Deddens 2001) or relationships
between dermal or environmental and bio-
marker measurements (Curl et al. 2002;
Franklin et al. 1981; Honeycutt et al. 2001;
Shealy et al. 1997). Although a number of stud-
ies have measured biomarkers of effect (Anwar
1997; Drevenkar et al. 1991; Hussain et al.
1990), fewer biomonitoring studies have been
designed to assess exposures and health out-
comes over either short or long time periods.
Considerable knowledge of farming operations,
exposure assessment, toxicokinetics, and analyt-
ical chemistry is needed for successful design,
implementation, and interpretation of farm-
worker biomonitoring studies.
Research publications and guidelines have
described considerations, procedures, and
issues in farmworker biomonitoring (Fenske
1997; Nigg and Stamper 1989). Honeycutt
(1986) described four criteria that must be
met for deriving exposure from measuring
pesticides or their metabolites in body ﬂuids:
a) the pesticide must be absorbed to an
appropriate extent, and dermal absorption
studies should be performed on appropriate
species; b) the toxicokinetics and excretion
kinetics in appropriate animals or humans
must be understood; c) the analytical method
must measure excreted parent compound or
metabolites and the method must have sufﬁ-
cient sensitivity to detect concentrations that
occur at the toxicologic no-effect level; and
d) collection methods should be convenient
for workers to gain their cooperation.
As with the criteria recommended by
Honeycutt (1986), the U.S. Environmental
Protection Agency (U.S. EPA 1996a, 1996b)
has developed occupational and exposure test
guidelines that include guidance for biological
monitoring studies. The feasibility of imple-
menting biological monitoring studies is deter-
mined by information available on the ADME
of the chemical of interest. The pathway for
measurements of biomonitoring of exposure in
farmworker studies is shown in Figure 3.
Designing Biomonitoring
Studies
Determining whether a biomonitoring study
is feasible is only the first step in designing
studies that assess exposure or differences in
exposure for an individual or between individ-
uals. Successful studies require using knowl-
edge of the ADME process and analytical
Barr et al.
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Figure 3. Pathway for biological measurements.chemistry to develop an implementation
approach that will meet study objectives for a
speciﬁc chemical. In particular, the timing of
biological sample collection is very critical
and highly dependent on both the exposure
scenario and the uptake and elimination
kinetics of the individual pesticides that may
depend largely on the pesticides chemical and
physical characteristics because, as stated pre-
viously, many pesticides are rapidly absorbed
and eliminated with biological half-lives of
6–48 hr. Biomonitoring to assess well-deﬁned
handling or task-related exposures requires
access to potential farmworker participants
and sample collection shortly before and for a
relatively short time (typically 1–5 days) after
the monitored activity.
Assessing long-term exposures to pesti-
cides may be of interest in studies of health
effect or health outcomes. Such an assessment
may be difﬁcult to implement, particularly for
NPPs with short biological half-lives. In such
cases, it will be necessary to collect biological
samples at multiple time points as pesticide-
related activities are repeated through a sea-
son. Such studies have been reported for
forestry workers (Lavy et al. 1993) and in a
multiday study of exposure of farmers, their
spouses, and their children to three pesticides
(Acquavella J, personal communication).
Human toxicokinetic information has been
reported for some chemicals, for example,
2,4-D (Sauerhoff et al. 1977), chlorpyrifos
(Nolan et al. 1984), and atrazine (Buchholz
et al. 1999); however, these data are lacking for
most pesticides. Hence, most pesticides will
require using animal data, where available, to
estimate human parameters and the uncer-
tainty of extrapolating these data to humans
must be recognized. However, a properly
designed biomonitoring study may provide
insights into whether animal and human toxi-
cokinetics for a given pesticide are similar. In
some cases, it may be feasible to measure the
parent compound in urine, blood, or saliva,
but most often metabolites of parent com-
pounds are measured in biological media. After
appropriate study design and protocol develop-
ment, the institutional review boards of partici-
pating groups must obtain human subjects’
approvals to ensure that the protocol complies
with all national and international guidelines
for the protection of research subjects.
Sampling Time Frame
The sampling time frame for NPPs is not
straightforward. Because these chemicals have
short biological half-lives, the samples,
whether blood, urine, or saliva, must be col-
lected soon after the exposure in order to
appropriately assess the exposure. In general,
sample collection for NPP measurements
should reﬂect the residence time of the chem-
ical in each individual matrix. The half-lives
of NPPs in blood are typically much less than
in urine samples. Thus, blood samples may
need to be collected within minutes or hours
after the exposure, whereas urine samples may
be collected several hours or, in some
instances, days after the exposure. However,
understanding the timing of exposure may
complicate the sample collection scheme
because very often the exposure time may not
be easily pinpointed. For example, farmwork-
ers may be unaware that a pesticide was
applied to a particular crop or what pesticide
was applied and thus would be unaware of
the exposure. Further, the contact with pesti-
cides could occur throughout the workday,
intermittently during the workday, or even
during one short segment of the workday.
Without having information on the precise
timing of exposure, the magnitude of the
exposure will be difﬁcult to estimate.
Temporal Variability 
in Biological Samples
The variability of NPP levels in samples col-
lected from an individual over time is of con-
cern whether the sample is biological or
environmental. Temporal variability can
include the variation of a given chemical in
multiple samples collected on a single day or
can include variation among days, months, or
seasons. For chronic exposures to pesticides, a
single sample will likely represent a day’s expo-
sure to a given chemical or exposure over a
longer period of time, because the exposure is
repeated. However, for episodic exposures, a
single sample may or may not represent a sin-
gle-day or longer-term exposure to a given
chemical. To further complicate the process,
the representativeness of a single spot sample
will likely vary from chemical to chemical and
among persons. In general, occupational expo-
sures such as those encountered by farmwork-
ers tend to be episodic, whereas environmental
exposures tend to be chronic with occasional
mini-episodic exposures. Farmworkers are
likely to encounter both occupational and
environmental exposures.
For urine matrix, a 24-hr urine sample is
preferred rather than a single spot sample on a
given day. Further, estimated total excretion of
certain pesticides/metabolites has been shown
to correlate highly with their levels in 24-hr
urine samples (Acquavella J, unpublished
observations). Collection of a 24-hr sample
before the monitored activity and collection of
24-hr samples from 1 to 5 days after the activ-
ity have been recommended (Honeycutt
1986; U.S. EPA 1996a, 1996b). Collection
and analysis of spot urine samples are some-
times used to reduce participant burden and
to avoid potential confounding from addi-
tional chemical uses. If spot samples are col-
lected, a ﬁrst morning void is often preferred
because the urine is more concentrated, the
collection represents a longer window of accu-
mulation (usually > 8 hr), and it is often corre-
lated with total excretion over 24 hr (Kissel
et al. 2005; Scher et al., in press). To evaluate
daily, monthly, or seasonal variations of ana-
lytes in urine, sequential samples are often
taken days and weeks apart to evaluate how
the intraindividual variation over time com-
pares with the interindividual variation and
whether an accurate classiﬁcation of exposure
is possible. Temporal variation studies are
important in interpreting the biomonitoring
data and should be considered, at some level,
in all biomonitoring studies. These data will
help to determine whether multiple samples
should be taken and at what intervals. In most
instances, sampling for nonpersistent chemi-
cals, whether environmental or biological, will
require multiple samples taken over the course
of the study at regular intervals (e.g., weekly,
monthly, semiannually, etc.).
Issues in Data Interpretation
The toxicokinetic process is complex and
dynamic and may vary based on demographic
variables such as age, sex, or race/ethnicity or
may change with diet, coexposures (e.g., envi-
ronmental chemicals, alcohol, tobacco, and
medications), and certain medical conditions.
The variability in the toxicokinetic process
makes interpretation of biomonitoring data
inherently complex. It is difﬁcult to gauge the
differences in the magnitude of exposures
among individuals based upon biological
measurements alone because their metabolism
may play a key factor in these differences.
Measurement of urinary biomarkers allows
direct assessment of exposure and dose for some
pesticides. For example, 2,4-D is largely unme-
tabolized, and > 95% is eliminated in urine
(Sauerhoff et al. 1977). Multiple elimination
routes and variable metabolism can complicate
the measurement and interpretation of bio-
markers for other chemicals. For example,
atrazine has been shown to have multiple uri-
nary metabolites (Buchholz et al. 1999). Large
interindividual differences in the formation of
the metabolites, and changes of the metabolite
proﬁle at different times after exposure further
complicate interpretation of exposure and dose
using urinary atrazine biomarkers (Buchholz
et al. 1999). Other pesticides may undergo sig-
nificant elimination through feces and sweat
that might not be accounted for in urine collec-
tions. Understanding intra- and interpersonal
variability in metabolism (e.g., the ability to
appropriately oxidize molecules using cyto-
chrome P450 enzymes or detoxify activated
molecules with paraoxonase activity) and excre-
tion will allow better assessment of the uncer-
tainty in concentration measurements and dose
estimations. Regardless, the interpretation of
biological data remains a complex process and
should be made with caution.
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can be confounded in several ways. The farm-
worker may have been exposed to the pesticide
of interest in the days before the monitored
activity. In this case, the biomarker level may
not be at a baseline before sample collection in
the study. In other cases, the farmworker may
be exposed to the chemical in days subsequent
to the monitored activity, potentially inter-
fering with results from multiday postapplica-
tion sample collections. Correction of pre- or
postactivity concentrations may be difﬁcult or
impossible unless the other exposure scenarios
are well deﬁned and the uptake and elimina-
tion kinetics well understood. Where feasible,
studies of exposure resulting from speciﬁc pes-
ticide handling or work tasks should be per-
formed with no other handling or work task
within several days before or after the moni-
tored activity. If that is not feasible, informa-
tion about the time, duration, and amount of
handling and work tasks should be collected
through questionnaires to allow better inter-
pretation of the monitored activity.
Interpretation of biological measurements
can also be complicated if the metabolite of
interest can be formed by different parent pes-
ticides. For example, 1-naphthol is a metabo-
lite of both naphthalene (used as a moth
repellent and also a polycyclic aromatic hydro-
carbon from combustion processes) and car-
baryl (Shealy et al. 1997). In this case, it may
be important to obtain information regarding
potential exposures to the other chemicals. The
most speciﬁc biomarker available for a particu-
lar chemical should be used whenever possible
to simplify interpretation. Emerging work also
suggests that people can be exposed to the
metabolite of a chemical in the environment
(Morgan et al. 2005; Wilson et al. 2003) or
through the diet (Lu et al. 2005). If the
metabolite is absorbed in the body, then distin-
guishing between exposure to the parent chem-
ical and the metabolite may create uncertainty
in the interpretation of the measurement.
Measurements to assess potential exposures to
metabolites should be performed to determine
whether the metabolite is present in the
worker’s environment in sufﬁcient quantities
to interfere with the biomonitoring study.
Successful interpretation of biological
measurements often requires collecting
important information from the farmworker
regarding the activities resulting in pesticide
exposures. Information about the start and
completion time for important activities is
needed in order to place the exposure in cor-
rect relation to the biological sample collec-
tion timing. Information about the work task
can be used to assess differences between
farmworker measurement results. Such infor-
mation might include use of specific equip-
ment or procedures and the number of times
activities were repeated. Information about
other potential exposure factors may be col-
lected to aid interpretation of results. Such
factors might include use of personal protec-
tive equipment or engineering controls,
hygiene activities and timing, food consump-
tion or smoking during the work period, and
possible spills or equipment leaks during pes-
ticide handling (Quandt et al. 2006).
There are several issues regarding interpre-
tation of urinary measurement results. For
spot samples, the concentration measurement
may not be representative of elimination 
over longer time periods because of short-term
volume and excretion rate differences. For
24-hr samples, there can be a high degree of
intra- and interindividual variability in 24-hr
urine volume, making uncorrected compar-
isons of concentrations across days and
between people difficult to interpret.
Researchers often fail to consider that the
24-hr collection period does not necessarily
translate directly to a 24-hr excretion period—
a period that may be several hours shorter or
longer depending on void times. Studies rely-
ing on single 24-hr samples should take the
excretion period into account when compar-
ing results among applicators.
Urinary creatinine is often used to adjust
for urine volume in biomonitoring for exoge-
nous chemical exposures. For some chemicals,
such corrections have been shown to reduce
uncertainties (Barber and Wallis 1986).
However, for some biomonitoring studies the
creatinine corrections have failed to improve,
or have actually increased, uncertainties (Berlin
et al. 1985). There are two reasons why creati-
nine corrections may not be appropriate for
pesticide biomonitoring. First, there is a wide
range of normal creatinine excretion in healthy
adults, making it difﬁcult to compare creati-
nine-adjusted results between people (Alessio
et al. 1985; Barr et al. 2005b). Second, rela-
tively large intraindividual daily variability in
creatinine excretion has been reported, suggest-
ing that even creatinine corrections between
24-hr periods for the same individual may not
be appropriate (Greenblat et al. 1976). The
underlying physiologic process of creatinine
formation and excretion can be dependent on
several factors, including age, gender, diet, exer-
cise, muscle mass, and underlying disease
(Boeniger et al. 1993). These processes may not
be the same as those governing metabolism and
excretion of pesticides.
Other parameters such as speciﬁc gravity
or osmolality have been suggested as a way to
adjust for variable urinary volumes. Another
approach using excretion rates has not been
widely reported but may deserve consideration
and testing. Under this approach, the excre-
tion rate is calculated for the urine sample and
used in analysis rather than the concentration.
To calculate the excretion rate information
about the total urine void volume, the start
and end times for collection of the urine sam-
ple, and the time of the previous void before
starting to collect the urine sample must be
known. This approach has the potential
advantages of accounting for all of the excre-
tion during a given time period and eliminat-
ing the urine volume issue. This approach
might not be appropriate if pesticide or pesti-
cide metabolite excretion is found to be
dependent on internal urine production rates.
Use of Biomonitoring in
Paraoccupational Exposure
Assessments
Paraoccupational exposures, often called take-
home exposures, are environmental exposures
that occur from the transfer of pesticides from
a person who is occupationally exposed to a
nonoccupational environment. Similar bio-
monitoring issues should be addressed when
evaluating paraoccupational exposures,
although the exposures may be expected to be
lower in magnitude and more difficult to
interpret. Urinary dialkylphosphate levels have
been used in many studies, which indicate
children are at risk of exposures to organo-
phosphorus pesticides based on their parental
occupation or their household proximity to
farmland (Koch et al. 2002; Lu et al. 2000),
self-reported residential use of pesticides by
the parents (Aprea et al. 2000; Lu et al. 2001)
or other factors (Aprea et al. 1996). However,
the uncertainties in these measurements
should also be considered to determine
whether the biomonitoring measurements
reflected true exposures or exposures to
environmental breakdown products.
What Can Biomonitoring
Measurements Really Tell Us?
Obviously, to yield the maximum information
from the biomonitoring component of a farm-
worker study, the ideal assessment should
include multiple, longitudinal 24-hr samples
after a known exposure event to a known
chemical with other potentially variable factors
narrowly controlled. In many farmworker
studies, however, many of these variables can-
not be feasibly controlled or even understood,
and the costs and participant burden may be
too large to bear. For example, often farm-
workers do not know if any pesticide has been
used on a field in which they are working.
Thus, it would be nearly impossible to deter-
mine the timing of exposure. In general, a sin-
gle spot-sample biomonitoring measurement
can allow a cross-sectional evaluation of
whether or not an exposure has occurred and
some information on the magnitude of expo-
sure, assuming the chemical measured is spe-
ciﬁc for a given exposure. To go beyond this
interpretation, additional information is neces-
sary. For example, if the exposure timing is
unknown, certain activities could be recorded
Barr et al.
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and the biomonitoring measurements evalu-
ated in relation to the specific activities.
Additionally, environmental or personal meas-
urements could be taken to evaluate the
potential for exposure from various activities.
Multiple measurements over time may allow
evaluation of the consistency of exposure,
especially if the same activity is performed
over that period of time.
If the biomonitoring measurements are to
be used to extrapolate back to the exposure,
additional information for that chemical such
as toxicokinetic data, rate of intake, and rate
of uptake may be required. Again, this still
would provide only a single measurement in
time. Multiple measurements over the dura-
tion of exposure-related activities must be
taken to determine peak exposures. To relate
the biomonitoring measurement to a health
outcome, other required information may
include population susceptibility factors,
plausible mechanism of toxicity, and informa-
tion on whether the exposure evaluated pre-
ceded the development of the health effect in
question. Of course, such exposure estimates
and health effects associations can be made
without the necessary information, but the
strength of the interpretation is weakened
because of the additional uncertainties associ-
ated with the assumptions made in lieu of the
required information.
Speciﬁc Recommendations
To allow better harmonization of data from
existing and future studies involving biomoni-
toring, we recommend several speciﬁc guide-
lines for study design and implementation
and for reporting data and study findings in
the peer-reviewed literature:
• The appropriateness of biomonitoring meas-
urements in the proposed study should be
considered.
• The frequency and timing of sample collec-
tion should be carefully evaluated, and an
adequate number of samples to describe the
exposure should be taken.
• Ideally, pre- and postexposure samples should
be collected. If the timing of exposure is un-
known, speciﬁc task-related activities should
be recorded for each study participant.
• Ideally, 24-hr samples should be collected. If
not possible, a ﬁrst morning void, noting the
time since last urination and the total urine
void volume, should be collected. If collect-
ing a spot sample is the only practical option,
the ability of a single spot sample to predict a
24-hr value should be evaluated in a pilot
study.
• Paraoccupational exposures should be evalu-
ated alongside farmworker exposure studies.
• The most selective analytes for assessing
exposures should be measured in biological
samples. Measurement of less selective
metabolites may allow for “class” exposure
assessment that may help to more narrowly
focus measures for subsequent studies.
• The most selective measurement techniques
for providing robust data should be
employed. However, the cost of the analysis
should be carefully weighed against the sam-
ple number requirements to ensure that the
overall cost is in keeping with the study
budget. Fewer “selective” measurements
may provide less meaningful data than a
larger number of samples with more general
measurements, depending upon the expo-
sure assessment question. The reverse can
also be true, depending upon the question.
• Analytic methods should be further devel-
oped allowing the analysis of potentially
useful biomolecular adducts that might
extend the window for capturing exposures
or allow more interpretable measurements
of internal doses.
• The uncertainties of biological measurements
should be considered when interpreting the
resulting data. The uncertainties associated
with the measurements and with the inter-
pretations and any assumptions made during
the process should be explicitly stated.
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